Compare LCII & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LCII | CORT |
|---|---|---|
| Founded | 1956 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.7B |
| IPO Year | 1994 | 2001 |
| Metric | LCII | CORT |
|---|---|---|
| Price | $125.77 | $33.70 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $120.00 | $105.20 |
| AVG Volume (30 Days) | 289.8K | ★ 1.7M |
| Earning Date | 05-19-2026 | 05-25-2026 |
| Dividend Yield | ★ 3.64% | N/A |
| EPS Growth | ★ 35.18 | N/A |
| EPS | ★ 7.57 | 0.82 |
| Revenue | ★ $4,122,017,000.00 | $761,407,000.00 |
| Revenue This Year | $5.17 | $29.97 |
| Revenue Next Year | $4.64 | $30.25 |
| P/E Ratio | ★ $16.75 | $40.98 |
| Revenue Growth | 10.18 | ★ 12.79 |
| 52 Week Low | $72.31 | $28.66 |
| 52 Week High | $159.66 | $117.33 |
| Indicator | LCII | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 27.94 | 33.92 |
| Support Level | $120.01 | $33.53 |
| Resistance Level | $151.85 | $41.92 |
| Average True Range (ATR) | 4.53 | 1.67 |
| MACD | -1.99 | 0.24 |
| Stochastic Oscillator | 4.26 | 14.66 |
LCI Industries Inc supplies domestically and internationally components for the original equipment manufacturers of recreational vehicles and adjacent industries including buses; and trailers used to haul boats, livestock, equipment, and other cargo. It has two reportable segments; the original equipment manufacturers segment and the aftermarket segment. The OEM Segment manufactures or distributes components for the OEMs of RVs and adjacent industries, including buses; trailers used to haul boats, livestock, equipment, and other cargo; trucks; pontoon boats; trains; manufactured homes; and modular housing. Its products are sold to manufacturers of RVs such as Thor Industries, Forest River, Winnebago, and other RV OEMs, and to manufacturers in adjacent industries.
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.